Scientific Presentation | AAN 2023
Fosgonimeton Provides Congruent Improvements on Neurodegeneration Biomarkers, Significantly Correlating With Composite Clinical Scores of Cognition and Function in Alzheimer's Disease
Hans J. Moebius, Kai-Bin Ooi, Michael D. Hale, Sharay E. Setti, Kayla N. Kleist, and Charles Bernick